Methenolone vs Drostanolone

Methenolone (B-tier) vs Drostanolone (B-tier). mechanism, trials, claims vs data, dosing literature. side-by-side reference.

Methenolone — tier B

a non-17-alpha-alkylated androgen with a current Japanese oral acetate label, historical injectable enanthate use, and no validated systemic half-life for either formulation.

Japan's current oral acetate label supplies a real foreign medical record, while the missing human PK and modern organ-safety file keep the evidence below top tier.

0 validated systemic half-life studies located · half-life unknown; no qualifying systemic plasma half-life located for acetate or enanthate · androgens

Drostanolone — tier B

a historical dromostanolone propionate breast-cancer drug with small human oncology series, no valid systemic half-life, and no current approved human product located.

the historical antitumor signal is human evidence, but it is old, small, formulation-specific, and missing the modern PK and safety limbs needed for confidence.

0 modern systemic human PK studies · half-life unknown; no qualifying systemic human or animal plasma half-life for dromostanolone propionate located · androgens

at a glance

• Methenolone: tier B · 0 validated systemic half-life studies located
• Drostanolone: tier B · 0 modern systemic human PK studies

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.